Johnson Investment Counsel Inc Mirati Therapeutics, Inc. Transaction History

Johnson Investment Counsel Inc

  • $9.44 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$132.01 - $190.29 $264,020 - $380,580
-2,000 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$72.01 - $120.39 $144,020 - $240,780
2,000 New
2,000 $228,000
Q1 2020

May 20, 2020
SELL
$69.78 - $116.21 $139,560 - $232,420
-2,000 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$70.76 - $128.86 $141,520 - $257,720
2,000 New
2,000 $258,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email